[go: up one dir, main page]

WO2005040338A3 - Immunogenes et anticorps alcaloides contraints et leurs utilisations - Google Patents

Immunogenes et anticorps alcaloides contraints et leurs utilisations Download PDF

Info

Publication number
WO2005040338A3
WO2005040338A3 PCT/US2004/016040 US2004016040W WO2005040338A3 WO 2005040338 A3 WO2005040338 A3 WO 2005040338A3 US 2004016040 W US2004016040 W US 2004016040W WO 2005040338 A3 WO2005040338 A3 WO 2005040338A3
Authority
WO
WIPO (PCT)
Prior art keywords
immunogens
antibodies
alkaloid
constrained
nicotine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2004/016040
Other languages
English (en)
Other versions
WO2005040338A2 (fr
Inventor
Kim D Janda
Peter Wirsching
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of WO2005040338A2 publication Critical patent/WO2005040338A2/fr
Publication of WO2005040338A3 publication Critical patent/WO2005040338A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne des immunogènes utilisés pour produire des anticorps anti-nicotine. L'invention concerne également des anticorps anti-nicotine qui réagissent de manière immunitaire avec les immunogènes et la nicotine et les utilisations de ces immunogènes et anticorps pour traiter l'addiction à la nicotine. L'invention concerne enfin des procédés permettant d'améliorer la capacité immunogène d'un haptène par introduction d'une modification afin de contraindre sa conformation.
PCT/US2004/016040 2003-05-21 2004-05-20 Immunogenes et anticorps alcaloides contraints et leurs utilisations Ceased WO2005040338A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47267103P 2003-05-21 2003-05-21
US60/472,671 2003-05-21

Publications (2)

Publication Number Publication Date
WO2005040338A2 WO2005040338A2 (fr) 2005-05-06
WO2005040338A3 true WO2005040338A3 (fr) 2005-10-27

Family

ID=34519951

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/016040 Ceased WO2005040338A2 (fr) 2003-05-21 2004-05-20 Immunogenes et anticorps alcaloides contraints et leurs utilisations

Country Status (1)

Country Link
WO (1) WO2005040338A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9402809B2 (en) 2006-03-16 2016-08-02 Niconovum Usa, Inc. Snuff composition

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2708552T3 (es) 2002-12-20 2019-04-10 Niconovum Ab Método para la preparación de un material particulado que contiene nicotina con una celulosa cristalina (en particular MCC)
EP2065398A1 (fr) 2007-11-29 2009-06-03 Cytos Biotechnology AG Anticorps spécifiques à la nicotine monoclonale humaine
WO2009120954A2 (fr) * 2008-03-27 2009-10-01 The Scripps Research Institute Immunoconjugués de nicotine
TWI578997B (zh) 2010-06-04 2017-04-21 輝瑞疫苗有限責任公司 用於預防或治療菸鹼成癮之共軛體
US9303013B2 (en) 2014-05-16 2016-04-05 Pfizer Inc. Conjugates and associated methods of producing them for the prevention or treatment of nicotine addiction

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999061054A1 (fr) * 1998-05-29 1999-12-02 Independent Pharmaceutica Ab Immunogene a la nicotine
US20030165950A1 (en) * 1998-12-01 2003-09-04 Nabi, Inc. Hapten-carrier conjugates for treating and preventing nicotine addiction
US20050089524A1 (en) * 2002-03-01 2005-04-28 Sanderson Sam D. Compositions and compounds for use as molecular adjuvant for a nicotine vaccine

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999061054A1 (fr) * 1998-05-29 1999-12-02 Independent Pharmaceutica Ab Immunogene a la nicotine
US20030165950A1 (en) * 1998-12-01 2003-09-04 Nabi, Inc. Hapten-carrier conjugates for treating and preventing nicotine addiction
US20050089524A1 (en) * 2002-03-01 2005-04-28 Sanderson Sam D. Compositions and compounds for use as molecular adjuvant for a nicotine vaccine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SHINGEKI J. ET AL: "An immunotherapeutic program for the treatment of nicotine addiction: Hapten designs and synthesis.", J.ORG, CHEM., vol. 66, 2001, pages 4115 - 4121, XP008050298 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9402809B2 (en) 2006-03-16 2016-08-02 Niconovum Usa, Inc. Snuff composition

Also Published As

Publication number Publication date
WO2005040338A2 (fr) 2005-05-06

Similar Documents

Publication Publication Date Title
SG157371A1 (en) Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines
AU2003284371A8 (en) Improved ethanol production process
PL1633876T3 (pl) Sposoby wytwarzania insuliny w roślinach
EP1514928A4 (fr) Procede de construction d'anticorps
ZA200405256B (en) Process for the production of hydrocarbons
EP1770212A4 (fr) Article forme en feuille, procede de fabrication dudit article et article forme exothermique
IL178233A0 (en) Process for producing 5-hydroxy-4-thiomethylpyrazole derivatives
GB2387599B (en) Methods for producing antibodies
EP1832188A4 (fr) Perruque et procede pour la produire
IL158016A (en) Method for preparing decorative elements
EP1876228A4 (fr) Procede de fabrication d'une boisson alcoolisee petillante et boisson alcoolisee petillante fabriquee par ce procede
EP1767538A4 (fr) Procédé pour la production d"un dérivé du 7alpha-méthoxy-3-chlorométhyle-1-oxacéphalosporine
WO2005040338A3 (fr) Immunogenes et anticorps alcaloides contraints et leurs utilisations
WO2007064478A3 (fr) Procede pour le marquage d’un haptene de la nicotine
MXPA03003874A (es) Un proceso para la produccion de cable relleno y tita chapeada para crear articulos ornamentales asi como articulos hechos similarmente.
GB2422842B (en) Process for the production of multipurpose energy sources and multipurpose energy sources produced by said process
PL1846412T3 (pl) Sposób wytwarzania 7-etylo-10-hydroksykamptotecyny
PT1663270E (pt) Processo para a preparação de um extracto de folhas de hera e extracto preparado de acordo com esse processo
AU2003280713A1 (en) Process for producing antibody
WO2004028452A3 (fr) Procede de preparation d'intermediaires acides a squelette crambescidine et leur utilisation dans la preparation d'analogues d'alcaloides de crambescidine en tant qu'agents therapeutiques
WO2005023758A3 (fr) Methode de preparation de losartan potassium de forme i
AU2001249546A1 (en) Methods for treating disease with antibodies to cxcr3
IL166793A0 (en) Process for producing indolopyrrolocarbazole derivative
EP1623969A4 (fr) Derive d'acide alpha-pentafluoroethylacrylique et son procede de preparation
SI1590351T1 (sl) Postopki za pripravo kinazolinskih alkaloidov

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase